The effect of Laser and Trans Epidermal Nerve Stimulation on Myofascial Pain Dysfunction Syndrome

Comparative evaluation of Low level laser therapy and Trans Epidermal Nerve stimulation as adjuvant therapies to drug therapy in Myofascial pain dysfunction syndrome

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

IRCT

Registry ID

IRCT201411113144N4

Enrollment

108

Registered

2015-09-05

Start date

2014-12-22

Completion date

Unknown

Last updated

2018-02-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Myofascial pain dysfunction syndrome. Disorders of muscles

Interventions

Intervention 1: Tablet Fluoxetin 10 mg(Tehran Daroo), once a day Tablet Clonazepam 0.25 mg(Sobhan Daroo), once a day Tablet Baclofen(Zahravi) 10 mg, three times a day. Intervention 2: low level las

Treatment - Drugs

Rehabilitation

Tablet Fluoxetin 10 mg(Tehran Daroo), once a day Tablet Clonazepam 0.25 mg(Sobhan Daroo), once a day Tablet Baclofen(Zahravi) 10 mg, three times a day

low level laser therapy( Ga-Al-Arsen,countinus wave, ?=660 nm, p=200 mW, t=10 s )10 sessions, 2 times a week

Trans epidermal nerve stimulation (TENS) (NEWTENS 900F, Novin medical Engineering, P= 20w, Voltage=220v, Freq=50Hz) 10 session, 3 times a week

Eligibility

Sex/Gender

All

Age

32 Years to 74 Years

Inclusion criteria

Inclusion criteria: Inclusion criteria: Age between 18-60 years; Pain and tenderness of masticatory muscles with or without limitation of range of motion, click in tempromandibular joint, deviation and deflection of mandible in opening; normal posterior occlusion; Orofacial pain existing at least for 6 months. Exclusion criteria: Tempromandibular joint disorders with articular origin according to RDC/TMD criteria; Systemic diseases including cardiovascular, infectious, inflammatory ,psychological diseases , seizures and tumors which can have effect on clinical appearance of the disease; Osteoartherities or hernia of the disc of neck vertebra; History of trauma; Removable prosthesis or missing of more than one tooth in each quadrant; Major malocclusion (anterior openbite, maxillary unilateral lingual crossbite, overjet > 6mm).

Exclusion criteria

Exclusion criteria:

Design outcomes

Primary

Measure	Time frame
Pain. Timepoint: before treatment, after each treatment session, after the end of treatment weekly up to 2 months. Method of measurement: visual analogue scale.	—

Countries

Iran (Islamic Republic of)

Contacts

Public ContactMaryam Sadat Sadrzadeh Afshar

Dental faculty, Tehran University of Medical Sciences

m_sadrzade@razi.tums.ac.ir+98 21 8835 1152

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 19, 2026